Tag: GlobeNewswire

BEIJING, Oct. 06, 2026 (GLOBE NEWSWIRE) — Elong Power Holding Limited (Elong Power, NASDAQ: ELPW, together with its subsidiaries and consolidated entities, the “Company”) today announced its unaudited financial results for the first half of fiscal year 2026 ended June 30, 2026 (the “First Half of 2026”). The Company has completed the divestment of its lithium battery manufacturing business, fully pivoted to an asset-light energy storage system integration business, and completed offerings with aggregate gross proceeds of approximately US$20 million, laying a solid funding foundation for its global energy storage market expansion.

First Half 2026 Financial and Operating Highlights

	●	Net revenue was US$2.90 million for the first half of fiscal year 2026, representing a substantial increase of 14,977% from US$19,229 in the same period of the prior year. This growth was primarily attributable to the significant ramp-up in sales of our energy storage system integration equipment and supporting accessories business;
	●	Gross profit was US$8,994 for the first half of fiscal year 2026, representing an increase of 368% from US$1,923 in the same period of the prior year; gross margin declined from 10.00% in the same period of the prior year to 0.3%, primarily due to the thin-margin operation of the energy storage system integration equipment and supporting accessories sales business in its early stage;
	●	Net income was US$20.49 million for the first half of fiscal year 2026, compared with a net loss of US$2.66 million in the same period of the prior year. This result was driven by a one-time, non-operating gain of US$22.61 million on the disposal of the lithium battery manufacturing business;
	●	Net loss from continuing operations (sales of energy storage system integration equipment and supporting accessories) was US$2.11 million for the first half of fiscal year 2026, widening from a net loss of US$1.42 million in the same period of the prior year;
	●	Both basic and diluted earnings per share were US$411 for the first half of fiscal year 2026, compared with a loss per share of US$3,071 in the same period of the prior year. The per-share amounts give retroactive effect to the 1-for-45 reverse share split effected August 10, 2026, after period end.

Management Commentary

Elong Power’s management stated: “The first half of 2026 marked a significant change in the Company’s business. We completed the divestment of our lithium battery manufacturing business and recognized a non-operating disposal gain, thereby pivoting to an asset-light energy storage system integration business and concentrating resources on the research and development and market development of energy storage products. Meanwhile, the Company completed an approximately US$20 million public market financing during the first half of 2026, providing solid funding support for energy storage product research and development and market promotion, and laying the foundation for the Company’s global energy storage market expansion. We believe that our asset-light model focused on the energy storage integration business will help drive long-term, sustainable value creation for the Company.”

Business Progress and Operational Review

1. Asset Divestment and Strategic Transformation: In March 2026, the Company completed the divestment of its lithium battery manufacturing subsidiary, adopted an asset-light operating model, and focused on the energy storage system integration business, while retaining its research and development, sales and full-lifecycle service capabilities. The disposal gains recognized from the divestment provided the primary support for the turnaround to profitability in the current period.

2. Public Market Financing: The Company completed offerings with aggregated gross proceeds of approximately US$20 million during the first half of 2026, providing funding support for energy storage product research and development and market promotion, and facilitating its global energy storage market expansion.

3. Operating Results: Net revenues in the current period were derived almost entirely from the sales of energy storage system integration equipment and supporting accessories. This business was still in its early stage with an extremely low revenue base in the same period of the prior year. During the current period, the Company focused on expanding its customer base and securing orders for energy storage products, and sales volume increased significantly, driving revenue from US$19,229 to US$2.90 million. Meanwhile, the business is currently a thin-margin business with limited per-unit gross profit. As sales volume grew, the consolidated gross margin declined from 10.00% in the same period of the prior year to 0.3%, with gross profit of only US$8,994, which was insufficient to cover selling, administrative and other operating expenses, resulting in a net loss of US$2.11 million from continuing operations in the current period.

About Elong Power

Elong Power Holding Limited is an exempted company incorporated under the laws of the Cayman Islands. Adhering to its development strategy of “Asset-Light, R&D-Intensive, AI + Energy Storage, Global Scenario Layout”, the Company focuses on lithium battery energy storage system core business, with strategic layout covering overseas residential & commercial and industrial (C&I) energy storage, as well as grid-side energy storage in China. The Company is committed to delivering high-reliability, cost-effective and intelligent energy storage system solutions to global customers. Elong Power is chaired and led by Ms. Xiaodan Liu as Chief Executive Officer.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar expressions, and include statements regarding the Company’s business strategy, its transition to an energy storage system integration business, its global expansion, its use of financing proceeds and its future results of operations. Such statements involve risks and uncertainties, including, among others: the Company’s limited operating history in the energy storage business; its ability to achieve positive gross margins and profitability from continuing operations; its need for additional financing and its ability to continue as a going concern; customer and supplier concentration; competition; related-party transactions; maintaining its Nasdaq listing; PRC regulatory, economic and currency risks; and the other risks described under “Item 3. Key Information—D. Risk Factors” in the Company’s most recent Annual Report on Form 20-F and other SEC filings. Actual results may differ materially. Except as required by law, the Company undertakes no obligation to update any forward-looking statement.

Investor & Media Contact

Elong Power Investor Relations
Email: ir@elongpower.com

ELONG POWER HOLDING LIMITED AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(Amount in U.S. dollars, except for number of shares or otherwise noted)

		As of June 30				As of December 31
		2026				2025
		(Unaudited)				(Audited)
ASSETS
Current assets:
Cash and cash equivalents			5,939,950				443,591
Short-term investments			2,940,490				7,165,232
Accounts receivable			220,295				889,533
Amounts due from related parties			138,091				71,499
Prepaid expenses and other current assets			8,874,078				2,066,487
Current assets held for sale associated with discontinued operation of ELPW			–				1,240,751
Total current assets			18,112,904				11,877,093
Equity method investment			4,572,796
Property, plant and equipment, net			100,255				117,453
Right-of-use assets, net			59,074				71,751
Non-current assets held for sale associated with discontinued operation of ELPW			–				15,674,938
Total non-current assets			4,732,125				15,864,142
Total assets			22,845,029				27,741,235
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Short-term loans-third parties			1,937,582				7,498,469
Short-term loans-related parties			4,679,224				2,030,366
Accounts payable			46,234				875,063
Amounts due to related parties			–				79,773
Contract liabilities			169,470				2,038,433
Accrued expenses and other current liabilities			842,508				1,812,778
Provision for product warranty, current			182,006				83,784
Lease liabilities, current			33,702				32,074
Current liabilities held for sale associated with discontinued operation of ELPW			–				11,436,442
Total current liabilities			7,890,726				25,887,182
Provision for product warranty, non-current			15,120				638
Lease liabilities, non-current			20,193				41,644
Non-current liabilities held for sale associated with discontinued operation of ELPW			–				24,555,631
Total non-current liabilities			35,313				24,597,913
Total liabilities			7,926,039				50,485,095
Class A Ordinary Shares, US$0.576 par value, 333,333,333 shares authorized, 1,065 shares issued and 769 outstanding as of December 31, 2025; 145,073* shares issued and 144,778 outstanding as of June 30, 2026;			83,392				443
Class B Ordinary Shares, US$0.576 par value, 83,333,333 shares authorized, 101 shares issued and outstanding as of December 31, 2025; 2,545 shares issued and outstanding as of June 30, 2026*			1,466				58
Treasury shares			(80	)			(80	)
Additional paid-in capital			67,725,796				51,070,354
Statutory Reserve			–				708,470
Accumulated deficit			(53,271,564	)			(74,474,141	)
Accumulated other comprehensive (loss) income			379,980				(48,964	)
Total shareholders’ equity (deficit)			14,918,990				(22,743,860	)
Total liabilities and shareholders’ equity (deficit)			22,845,029				27,741,235

	*	Including 295 shares issued but not outstanding, consisting of 156 forfeited Earnout Shares pending cancellation and 139 shares held as treasury stock reserved for future issuance, as discussed in Note 17.
	*	Giving retroactive effect to the 1-for-45 reverse share split effected on August 10, 2026.

ELONG POWER HOLDING LIMITED AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(Amount in U.S. dollars, except for number of shares or otherwise noted)

		For the six months ended June 30,
		2026				2025
		Unaudited				Unaudited
Revenues		$	2,899,110			$	19,229
Cost of revenues			(2,890,116	)			(17,306	)
GROSS PROFIT			8,994				1,923
OPERATING EXPENSES
Selling expenses			(505	)			(19,985	)
General and administrative expenses			(1,809,901	)			(1,252,874	)
TOTAL OPERATING EXPENSES			(1,810,406	)			(1,272,859	)
OPERATING LOSS			(1,801,412	)			(1,270,936	)
OTHER (EXPENSE) INCOME
Interest income			59,148				200
Interest expense			(206,698	)			(22,899	)
Foreign currency exchange losses, net			(255,926	)			(128,947	)
Share of profit from equity method investment			180				–
Fair value losses on short-term investments			(186,854	)			–
Other income			281,267				–
TOTAL NON OPERATING EXPENSE, NET			(308,883	)			(151,646	)
LOSS BEFORE INCOME TAXES			(2,110,295	)			(1,422,582	)
INCOME TAX EXPENSE			–				–
NET LOSS FROM CONTINUING OPERATIONS			(2,110,295	)			(1,422,582	)
DISCONTINUED OPERATIONS:
Loss from discontinued operations			(2,002	)			(1,232,895	)
Gain on disposal of subsidiaries			22,606,404				–
NET INCOME(LOSS) FROM DISCONTINUED OPERATIONS			22,604,402				(1,232,895	)
NET INCOME (LOSS)		$	20,494,107			$	(2,655,477	)
Net income (loss) per share attributable to ordinary shareholders of the Company-Basic and Diluted *
Continuing operations			(42.36	)			(1,645.40	)
Discontinued operations			453.73				(1,426.00	)
Total basic and diluted		$	411.37			$	(3,071.40	)
WEIGHTED AVERAGE SHARES OUTSTANDING USED IN CALCULATING BASIC AND DILUTED LOSS PER SHARE
Class A and Class B Ordinary Shares			49,819				865

*

Giving retroactive effect to the 1-for-45 reverse share split effected on August 10, 2026.

ELONG POWER HOLDING LIMITED AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025
(Amount in U.S. dollars, except for number of shares or otherwise noted)

		For the six months ended June 30,
		2026				2025
Cash flows from operating activities
Net income (loss)		$	20,494,107			$	(2,655,477	)
Provision for losses on accounts receivable			–				23,132
Provision of obsolete inventory			–				148,912
Depreciation and amortization expense			25,488				60,221
Interest on lease liabilities			1,323				3,678
Amortization of operating and finance right-of-use assets			14,883				820,287
Gain on disposals of property, plant and equipment			–				(66,138	)
Gain from debt forgiveness			–				(7,218	)
Provision (reversal) for warranty liability			108,876				(153,845	)
Fair value losses on short-term investments			186,854				–
Share of profit from equity method investment			(180	)			–
Gain on disposal of subsidiaries			(22,606,404	)			–
Changes in operating assets and liabilities:
Accounts receivable			682,962				(276,816	)
Inventories			–				(38,474	)
Amounts due from related parties			(128,072	)			–
Prepaid expenses and other current assets			(7,349,365	)			(28,014	)
Long term accounts receivable			–				99,183
Accounts and notes payable			(795,842	)			50,904
Amounts due to related parties			–				140,972
Contract liabilities			(1,791,605	)			150,313
Accrued expenses and other current liabilities			4,106,253				156,703
Product warranty liability			53,791				(38,229	)
Lease liability			(53,895	)			–
Net cash used in operating activities			(7,050,826	)			(1,609,906	)
Cash flows from investing activities
Purchase of property, plant and equipment			(5,128	)			(62,254	)
Proceeds from disposal of short term investments			2,045,400				–
Placement of short-term investments			(4,132,849	)			–
Placement of equity method investment			(4,572,616	)			–
Disposal of subsidiaries, net of cash disposed			(123,021	)			–
Net cash used in investing activities			(6,788,214	)			(62,254	)
Cash flows from financing activities
Proceeds from borrowings from related parties			4,568,835				1,280,093
Repayment of borrowings to related parties			(873,231	)			–
Proceeds from borrowings from third parties			1,289,909				322,045
Repayments of borrowings to third parties			(2,189,134	)			(31,269	)
Offering costs			(1,702,120	)			–
Proceeds from issuance of common stock			18,328,919				–
Net cash provided by financing activities			19,423,178				1,570,869
Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash			(216,732	)			(16,182	)
Net increase in cash, cash equivalents and restricted cash			5,367,406				(117,473	)
Cash and cash equivalents and restricted cash, beginning of period			572,544				318,001
Cash and cash equivalents and restricted cash, end of period		$	5,939,950				200,528
Supplemental disclosure of cash flow information:
Issuance of Class B ordinary shares for Debt Settlement			48,600				–
Issuance of Class B to a shareholder			64,400				–
Short term investment Redemption Proceeds Applied to Offset Loans			6,289,040				–
Lease liabilities arising from obtaining right-of-use assets			–				311,871

Founder and CEO Rohan Malhotra to Join “The Shifting Landscape of AI” Panel at Maxim, Present at ThinkEquity and Hold One-on-One Meetings with Institutional Investors

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) — Roadzen Inc. (Nasdaq: RDZN), a global leader in AI at the intersection of insurance and mobility, today announced that Founder and Chief Executive Officer Rohan Malhotra will present at both the 2026 Maxim Growth Summit and The ThinkEquity Conference in New York during the week of October 12, 2026.

2026 Maxim Growth Summit
Date: October 13, 2026
Location: Hard Rock Hotel New York
Panel: “The Shifting Landscape of AI”
Time: 1:30 p.m. – 2:30 p.m. ET
Investor Meetings: One-on-one meetings will be held during the conference

Mr. Malhotra will join the panel discussion, “The Shifting Landscape of AI,” and discuss the evolving AI landscape alongside other industry leaders. He will also hold one-on-one meetings with institutional investors during the conference.

The ThinkEquity Conference
Date: October 15, 2026
Location: Mandarin Oriental, New York
Company Presentation: Rohan Malhotra, Founder and CEO
Time: 9:30 a.m. ET
Investor Meetings: One-on-one meetings will be held throughout the day

During the conferences, management expects to discuss Roadzen’s AI-powered insurance and mobility platform, recent business developments and the Company’s strategy for continued growth across its global operations.

Investors interested in scheduling a one-on-one meeting with Roadzen management should contact their respective Maxim Group or ThinkEquity representative.

About Roadzen Inc.
Roadzen Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers, automakers, and fleets better predict and prevent risk, automate claims, and deliver seamless, embedded insurance experiences. Thousands of clients across North America, Europe, and Asia — from the world’s leading insurers, carmakers, and fleets to dealerships and agents — use Roadzen’s technology to build new products, sell insurance, process claims, and improve road safety. Roadzen’s pioneering work in telematics, generative AI, and computer vision has earned recognition from Forbes, Fortune, and Financial Express as one of the world’s top AI innovators. Headquartered in Burlingame, California, Roadzen employs more than 450 people across offices in the U.S., U.K., India and China. Learn more at www.roadzen.ai.

About Maxim Group and the Maxim Growth Summit
Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The independent, employee-owned firm provides a broad range of financial services, including investment banking, private wealth management, institutional equity, fixed-income and derivatives sales and trading, equity research and prime brokerage services.   For more information, visit www.maximgrp.com.

The 2026 Maxim Growth Summit, being held October 12–14 at the Hard Rock Hotel New York, brings together industry leaders, innovators and institutions and includes one-on-one meetings with institutional investors and discussions across sectors including artificial intelligence, biotechnology, quantum technology, digital assets, energy and mining, drones and other emerging industries. For more information and a complete agenda of the Maxim Growth Summit, please visit www.maximgrp.com/2026-growth-summit.

About ThinkEquity and The ThinkEquity Conference
ThinkEquity LLC is a boutique investment bank providing a range of services to growth companies, including public and private capital raising, investment banking, equity research, institutional sales and trading, debt capital markets and mergers and acquisitions.

The ThinkEquity Conference brings together public and private companies, institutional and accredited investors, and industry executives for company presentations and one-on-one investor meetings. Past conferences have included more than 85 company presentations, 750 attendees and 750 one-on-one meetings. The 2026 conference will feature companies across sectors including artificial intelligence, biotechnology, drones, metals and mining, oil and gas, space and technology.   For more information, visit www.think-equity.com.

Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” and “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding anticipated revenue and EBITDA, our anticipated strategy, valuation, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in “Risk Factors” in our Securities and Exchange Commission (“SEC”) filings, including the annual report on Form 10-K we filed with the SEC on June 29, 2026. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:
Investor Contacts: IR@roadzen.ai
Media Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai

Founder and CEO Rohan Malhotra to Join “The Shifting Landscape of AI” Panel at Maxim, Present at ThinkEquity and Hold One-on-One Meetings with Institutional Investors

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) — Roadzen Inc. (Nasdaq: RDZN), a global leader in AI at the intersection of insurance and mobility, today announced that Founder and Chief Executive Officer Rohan Malhotra will present at both the 2026 Maxim Growth Summit and The ThinkEquity Conference in New York during the week of October 12, 2026.

2026 Maxim Growth Summit
Date: October 13, 2026
Location: Hard Rock Hotel New York
Panel: “The Shifting Landscape of AI”
Time: 1:30 p.m. – 2:30 p.m. ET
Investor Meetings: One-on-one meetings will be held during the conference

Mr. Malhotra will join the panel discussion, “The Shifting Landscape of AI,” and discuss the evolving AI landscape alongside other industry leaders. He will also hold one-on-one meetings with institutional investors during the conference.

The ThinkEquity Conference
Date: October 15, 2026
Location: Mandarin Oriental, New York
Company Presentation: Rohan Malhotra, Founder and CEO
Time: 9:30 a.m. ET
Investor Meetings: One-on-one meetings will be held throughout the day

During the conferences, management expects to discuss Roadzen’s AI-powered insurance and mobility platform, recent business developments and the Company’s strategy for continued growth across its global operations.

Investors interested in scheduling a one-on-one meeting with Roadzen management should contact their respective Maxim Group or ThinkEquity representative.

About Roadzen Inc.
Roadzen Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers, automakers, and fleets better predict and prevent risk, automate claims, and deliver seamless, embedded insurance experiences. Thousands of clients across North America, Europe, and Asia — from the world’s leading insurers, carmakers, and fleets to dealerships and agents — use Roadzen’s technology to build new products, sell insurance, process claims, and improve road safety. Roadzen’s pioneering work in telematics, generative AI, and computer vision has earned recognition from Forbes, Fortune, and Financial Express as one of the world’s top AI innovators. Headquartered in Burlingame, California, Roadzen employs more than 450 people across offices in the U.S., U.K., India and China. Learn more at www.roadzen.ai.

About Maxim Group and the Maxim Growth Summit
Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The independent, employee-owned firm provides a broad range of financial services, including investment banking, private wealth management, institutional equity, fixed-income and derivatives sales and trading, equity research and prime brokerage services.   For more information, visit www.maximgrp.com.

The 2026 Maxim Growth Summit, being held October 12–14 at the Hard Rock Hotel New York, brings together industry leaders, innovators and institutions and includes one-on-one meetings with institutional investors and discussions across sectors including artificial intelligence, biotechnology, quantum technology, digital assets, energy and mining, drones and other emerging industries. For more information and a complete agenda of the Maxim Growth Summit, please visit www.maximgrp.com/2026-growth-summit.

About ThinkEquity and The ThinkEquity Conference
ThinkEquity LLC is a boutique investment bank providing a range of services to growth companies, including public and private capital raising, investment banking, equity research, institutional sales and trading, debt capital markets and mergers and acquisitions.

The ThinkEquity Conference brings together public and private companies, institutional and accredited investors, and industry executives for company presentations and one-on-one investor meetings. Past conferences have included more than 85 company presentations, 750 attendees and 750 one-on-one meetings. The 2026 conference will feature companies across sectors including artificial intelligence, biotechnology, drones, metals and mining, oil and gas, space and technology.   For more information, visit www.think-equity.com.

Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” and “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding anticipated revenue and EBITDA, our anticipated strategy, valuation, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in “Risk Factors” in our Securities and Exchange Commission (“SEC”) filings, including the annual report on Form 10-K we filed with the SEC on June 29, 2026. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:
Investor Contacts: IR@roadzen.ai
Media Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai

Landsbankinn will offer covered bonds for sale via auction held on Thursday 8 October at 15:00. The non-indexed series LBANK CB 32, will be offered for sale.

In connection with the auction, a covered bond exchange offering will take place, where holders of the inflation-linked series LBANK CBI 26 can sell the covered bonds in the series against covered bonds bought in the above-mentioned auction. The clean price of the bonds is predefined at 99.855.

Expected settlement date is 15 October 2026.

The covered bonds will be issued under the bank’s covered bond programme. Covered bonds issued by Landsbankinn are rated A+ with positive outlook by S&P Global Ratings.

Landsbankinn Capital Markets will manage the auction. For further information, please call +354 410 7330 or email verdbrefamidlun@landsbankinn.is.

Landsbankinn will offer covered bonds for sale via auction held on Thursday 8 October at 15:00. The non-indexed series LBANK CB 32, will be offered for sale.

In connection with the auction, a covered bond exchange offering will take place, where holders of the inflation-linked series LBANK CBI 26 can sell the covered bonds in the series against covered bonds bought in the above-mentioned auction. The clean price of the bonds is predefined at 99.855.

Expected settlement date is 15 October 2026.

The covered bonds will be issued under the bank’s covered bond programme. Covered bonds issued by Landsbankinn are rated A+ with positive outlook by S&P Global Ratings.

Landsbankinn Capital Markets will manage the auction. For further information, please call +354 410 7330 or email verdbrefamidlun@landsbankinn.is.

Transaction in Own Shares

October 05, 2026

• • • • • • • • • • • • • • • •

Shell plc (the ‘Company’) announces that on 05 October 2026 it purchased the following number of Shares for cancellation.

Aggregated information on Shares purchased according to trading venue:

Date of Purchase	Number of Shares purchased	Highest price paid	Lowest price paid	Volume weighted average price paid per share	Venue	Currency
05/10/2026	825,000	£ 36.3750	£ 35.7950	£ 36.1340	LSE	GBP
05/10/2026	–	–	–	–	Chi-X (CXE)	GBP
05/10/2026	–	–	–	–	BATS (BXE)	GBP
05/10/2026	380,000	€ 43.1050	€ 42.3550	€ 42.7918	XAMS	EUR
05/10/2026	–	–	–	–	CBOE DXE	EUR
05/10/2026	–	–	–	–	TQEX	EUR

These share purchases form part of the on- and off-market limbs of the Company’s existing share buy-back programme previously announced on 30 July 2026. 

In respect of this programme, Goldman Sachs International will make trading decisions in relation to the securities independently of the Company for a period from 30 July 2026 up to and including 23 October 2026.

The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020)  through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.

In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Goldman Sachs International on behalf of the Company as a part of the buy-back programme is detailed below.

Enquiries:

Media International: +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html

Attachment

• 20261005_Shell RNS – full version

Auction	Auction results
Auction date	2026-10-06
Start date	2026-10-07
Maturity date	2026-10-14
Interest rate	1.75 %
Offered volume, SEK bn	471.0
Total bid amount, SEK bn	353.9
Accepted volume, SEK bn	353.9
Number of bids	12
Percentage allotted, %	100.00

• Asset rotation accelerates: €260mn signed YTD at a 17% premium to GAV and a 42% gross margin, including a new €110mn JV – smart capital allocation in action 
• 2026 on track: Neinor confirms guidance, doubling net income and will pay the remaining c.€80mn dividend (€0.82/sh) in December, increasing shareholder remuneration to c.€280mn, all while integrating AEDAS
• 2027 raised: EBITDA up 8% to €260–280mn, net income to the high end (€160–170mn) and net debt guidance improved to €800–850mn – c.60% of the c.€250mn dividend is brought forward to 1H27
• 2028 unveiled: Backed by strong business visibility, Neinor guides to €260–280mn EBITDA, €160–170mn net income, €200–250mn of distributions and net debt down to €550–650mn, taking shareholder returns to c.€555mn (€5.71/sh) over the next two years

Madrid, 5 October 2026 – Neinor Homes (“Neinor” or the “Company”), Spain’s leading residential developer, announces the acceleration of its asset rotation plan, with €260mn signed year-to-date at a 17% premium to GAV and a 42% gross margin. Despite a complex geopolitical and macroeconomic environment, this faster-than-expected execution significantly improves the Company’s cash flow generation profile and de-risks its business plan, with strong visibility not only in 2026 but also over 2027–28. It also allows Neinor to accelerate its 2027 shareholder remuneration while reducing net debt and, as a result, to upgrade the guidance unveiled at its AGM in April 2026.

Acceleration in asset rotation confirms Neinor’s disciplined investment strategy

The €260mn asset rotation plan includes the sale of a €110mn land portfolio to a new joint venture (JV) with Orion Capital Managers, Neinor’s largest shareholder, in which Orion holds a 90% interest and Neinor 10%. The portfolio comprises land not yet in development and not scheduled for delivery in the coming years. The transaction was awarded through a competitive process coordinated by Alantra, an independent adviser, which approached more than 30 investors. Orion submitted the most compelling offer, supported by its deep knowledge of the Spanish residential market.

Neinor monetises land at a premium to the acquisition cost of AEDAS earlier this year, retains exposure to the projects through its 10% equity stake and earns management fees and promote on top. Neinor expects to deliver at least the profits assumed in the business plan, with cash flows brought forward by more than two years. This is the same playbook executed with Joaquín Lorenzo and AXA in 2023, and earlier this year with Río Real and Stoneshield. It confirms the significant value embedded in Neinor’s land bank.

In addition, as part of the €400mn asset rotation plan for 2026–27 and the land bank optimisation strategy, the Company has up to €100mn under negotiation, as it capitalises on a buoyant Spanish residential market and strong appetite from institutional investors to invest alongside Neinor.

A de-risked 2026–28 plan supports strong shareholder returns and faster deleveraging 

Visibility on the business plan has improved significantly throughout the year. Neinor has an excellent forward-sold position, with a record orderbook of over €2bn and 92%, 84% and 38% of 2026, 2027 and 2028 deliveries pre-sold. Construction risk is mitigated, with turnkey contracts already in place for over 70% of 2028 target deliveries. Interest rate risk is hedged across corporate debt and development loans against Euribor above 3%. Altogether, this gives Neinor greater comfort in reiterating its 2026 guidance, lifting 2027 towards the high end of the ranges and extending visibility into 2028, while it continues to further optimise pricing, structure and financial costs.

• 2026: The closing of the Orion transaction allows Neinor to reiterate its 2026 guidance of €240–260mn EBITDA and €120–140mn net income (€1.23–1.44/sh). The notarisation of Río Real remains pending. 
• 2027: With improved visibility on the business plan, Neinor raises its 2027 targets towards the high end of its April AGM guidance: €260–280mn EBITDA (previously €240–260mn) and €160–170mn net income (previously €150–170mn), or €1.65–1.75/sh. 
• 2028: For the first time, Neinor extends its guidance to 2028, with targets broadly in line with 2027 (€260–280mn EBITDA, €160–170mn net income).

Shareholder distributions. Better-than-expected cash flow generation allows Neinor to increase 2026 distributions through the inclusion of the share buyback programme (1.65mn shares to be cancelled) and to bring forward c.60% of the 2027 target. In addition, given the visibility over 2028, Neinor is targeting distributions of €200-250mn in 2028, bringing total distributions over the coming two years to c.€555mn (€5.71/sh). Upcoming payments:

• 2026: The remaining c.€80mn (€0.82/sh) is expected to be paid in December.

• 2027: The first two distributions of c.€70mn (€0.72/sh) each, are brought forward to February (1Q27) and April/May (2Q27), accelerating c.60% of the €250mn annual target (€2.58/sh).  

Net debt. Despite accelerating distributions, Neinor expects net debt to decline faster than previously guided. By December 2026, net debt is expected at €1,000–1,100mn, an unchanged range that now absorbs the €50mn total share buyback including management incentive plan (not included in the AGM guidance), and 100% of the full-year dividend target, a like-for-like improvement. By December 2027, net debt is expected at €800–850mn, 6% below the company compiled consensus of €881mn. For 2028, Neinor guides to net debt of €550–650mn, 16% below the consensus of €711mn.

(€mn, unless stated otherwise)	2026 Previous	2026 New2	2027 Previous	2027 New2	2028           New2
EBITDA¹	240–260	240–260	240–260	260–280	260–280
Net income¹	120–140	120–140	150–170	160–170	160–170
EPS (€/sh)¹	1.21–1.42	1.23–1.44	1.52–1.72	1.65–1.75	1.65–1.75
Shareholder remuneration	250	c.280	250	250 (accelerated)	200–250
DPS (€/sh)	2.52	2.54	2.58	2.58	2.06–2.58
Net debt	1,000–1,100	1,000–1,100	800–900	800–850	550–650

1. Adjusted for one-off expenses and purchase price allocation (non-cash item). 2. Adjusted by 1.65mn treasury share cancellation

Jordi Argemí, Neinor Homes’ CEO, commented: “The challenge this year could not have been bigger: multiplying revenues, EBITDA and net income by 2x in the very same year we are integrating AEDAS. Yet, barely six months after completing the tender offer, we have de-risked our business plan at an accelerated pace and today we come to the market with a guidance upgrade, faster deleveraging than planned and accelerated returns to our shareholders. Our homework for 2026 is done. We have a very strong team, and from this position of strength we are ready to keep executing flawlessly and to go after the upsides, because complex environments also bring good opportunities.”

Mario Lapiedra, CIO and Deputy CEO of Neinor Homes, added: “With this transaction we are rotating €110mn of land and while keeping a stake in the upside and earning fees as manager. By co-investing alongside Orion and remaining fully aligned as manager and shareholder in the venture, we can bring these projects forward while using our capital more efficiently. Investor decision to back this portfolio reflects the quality of the land we have assembled and the strength of our development platform. Partnerships like this one allow us to maximise ROE and grow with investors who share our long-term view of the Spanish residential market.”

 

For more information

 

NEINOR HOMES

Departamento de Relación con Inversores

investor.relations@neinorhomes.com

 

LLYC

Elena Torres – etorresq@llyc.global

Natalia Guerrero – natalia.guerrero@llyc.global

Attachment

• 2026.10.05 PR Neinor seals new €110mn JV, brings cash forward and improves guidance to 2028 (2)

Press Release

Atos positioned as a Leader in cybersecurity solutions and services in the 2026 ISG Provider Lens™ report for France

Paris, France – October 6, 2026 – Atos, a global leader of AI-powered digital transformation, today announced that it has been positioned as a Leader in three strategic segments of the 2026 ISG Provider Lens™ report on cybersecurity solutions and services in France: Next-Gen SOC/MDR Services, Strategic Security Services and Technical Security Services.

Organizations are facing increasingly sophisticated, unpredictable and difficult-to-contain cyberattacks across complex cloud and hybrid environments. Growing regulatory compliance requirements present an additional challenge. In this context, according to ISG, standalone security tools are no longer sufficient, and organizations need to implement a comprehensive cybersecurity strategy. ISG recognizes Atos’ ability to deliver such an approach, based on its expertise in advanced technologies, its knowledge of the regulatory landscape and its operational excellence.

Next-Gen SOC/MDR Services

The report highlights the maturity of Atos’ SOC/MDR services for large enterprises, public-sector organizations and critical infrastructure operators, as well as its position as a sovereign European provider headquartered in France. ISG also emphasizes the scale of Atos’ network of next-generation security operations centers and its ability to combine managed incident response services with OT environments.

“Atos differentiates itself through proven SOC/MDR services with extensive detection, response, remediation and recovery capabilities, including incident response services tailored to large enterprises and public-sector organizations,” said Benoît Scheuber, principal consultant and security analyst at ISG.

Strategic Security Services

ISG recognizes the breadth of Atos’ strategic cybersecurity consulting portfolio. This enables the company to meet the needs of organizations seeking a provider capable of integrating risk, policy, compliance and transformation within a single consulting framework.

“Atos is recognized for its strategic security expertise, combining governance, compliance, resilience and identity management consulting services that are particularly well suited to large organizations operating in highly regulated environments,” added Benoît Scheuber, principal consultant and security analyst at ISG.

Technical Security Services

The report highlights Atos’ ability to deliver technical expertise at scale across environments with demanding criticality and resilience requirements, for both public and private-sector organizations. Atos’ established expertise in identity and access management (IAM), together with its continued investments in this field and in Zero Trust architecture, enables the company to design and deploy end-to-end protection architectures across all types of digital environments.

“Atos differentiates itself through deep technical security expertise, strong capabilities in identity and infrastructure, and a trusted position in complex, highly regulated environments,” said Benoît Scheuber, principal consultant and security analyst at ISG.

Farah Rigal, head of cybersecurity services France, Atos, said: “This positioning recognizes our commitment to anticipating and managing cyber risks, as well as the technological and industry expertise of our teams in strengthening organizations’ protection and resilience. Our services, operated under ANSSI qualifications where needed, address our clients’ needs for continuous compliance, proactive managed detection and response, identity and access protection, and AI-powered operations automation under the supervision of our experts.”

To download the report, please click HERE

***

Atos Group’s cybersecurity services and products

As a global cybersecurity leader with more than 6,500 experts and 205 cybersecurity patents, Atos Group helps organizations navigate the evolving threat landscape with end-to-end, AI-powered security, enabling their pursuit of digital sovereignty and trust.

Cybersecurity services, delivered under the Atos brand, offer an integrated blend of strategic consulting, solution integration and continuous managed security services – spanning the entire security lifecycle. With a global network of 17 security operations centers (SOCs) processing more than 31 billion security events per day and serving over 2,000 trusted customers, Atos cybersecurity services deliver a proactive, globally informed approach to securing operations. Its teams operate with deep industry expertise across all sectors, ensuring robust data protection, regulatory compliance, and business continuity worldwide.

Cybersecurity products, delivered under the Eviden brand, consist of a sovereign portfolio built on three complementary areas of expertise: data encryption, identity and access management, and digital identity.  Developed and manufactured in Europe, Eviden cybersecurity products comply with the highest European certification standards to safeguard sensitive data, secure digital access and protect the identities across users, systems, and connected devices.

***

About Atos

Atos is the Atos Group brand dedicated to AI-powered, secure, end-to-end digital services. Atos designs, develops, and operates critical digital environments that drive performance, resilience and sovereignty, helping public and private organizations worldwide retain control over their data and infrastructures, while meeting regulatory requirements.

With more than 52,000 employees serving over 4,500 clients across 54 countries, Atos helps modernize core IT systems, accelerate cloud and data transformation, strengthen cybersecurity, and deliver secure digital workplace environments to support its clients, its employees and society. Atos also provides consulting and advisory services through its Atos Amplify brand.

A trusted partner in operating complex and mission-critical environments, Atos supports organizations across highly regulated and sovereign contexts.

About Atos Group

Atos Group is a global leader in digital transformation with c. 54,000 employees and annual revenue of c. €7.2 billion, operating in 54 countries under two brands – Atos for services and Eviden for products and systems. European number one in cybersecurity and a leader in cloud, Atos Group is committed to a secure and decarbonized future and provides tailored AI-powered, end-to-end solutions for all industries. Atos Group is listed on Euronext Paris. 

Press contact

Isabelle Grangé | isabelle.grange@atosgroup.com | +33 (0) 6 64 56 74 88

Attachment

• PR-Atos positioned as a Leader in cybersecurity solutions and services in the 2026 ISG Provider Lens™ report for France

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe. The CARTIHEAL Implant will take center stage at this week’s International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit in Porto, Portugal from October 8-10.

Introduced by Smith+Nephew in the US during 2024, the CARTIHEAL Implant is rapidly transforming the cartilage repair landscape. Composed of aragonite, a naturally occurring calcium carbonate acting as a biphasic scaffold, the implant is able to repair cartilage, restore bone, and relieve pain.^1–5,* These unique properties enable physicians to surgically treat patients who previously had no access to cartilage repair procedures.^1,4,5

Click here to play video

Compelling evidence from a multicenter, randomized controlled trial highlighting the clinical superiority of the CARTIHEAL Implant was recently published in the American Journal of Sports Medicine (AJSM). The study concluded that the CARTIHEAL AGILI-C Cartilage Repair Implant resulted in higher overall Knee injury and Osteoarthritis Outcome Scores (KOOS) versus surgical standard of care^** for all time points out to 60 months.⁵

Additionally, the study also found:

• Superior pain relief: Patients treated with the CARTIHEAL AGILI-C Implant reported significantly better knee pain relief and quality of life improvements over a 5-year period.^1,4-6,*
• Superior functional gains: Patients treated with the CARTIHEAL Implant reported superior improvements in performing activities related to daily living, sport and recreation at 2, 4 and 5-years.^1,4-6
• Patients with/without osteoarthritis (OA): No statistical difference in clinical outcomes found in OA and non-OA patients receiving the CARTIHEAL Implant.^4,***

Joaquin Lasso, Smith+Nephew’s SVP and GM of Sports Medicine International commented, “Smith+Nephew is committed to advancing technologies that address meaningful unmet clinical needs. The launch of the CARTIHEAL Implant in Europe brings surgeons an innovative, evidence-backed solution for cartilage repair and reinforces our focus on helping patients achieve better long-term outcomes and return to their active lives.”

“The treatment of cartilage and osteochondral defects continues to be one of the most challenging areas in Orthopedic sports medicine. It is encouraging to see innovative treatment approaches such as the CARTIHEAL AGILI-C Implant becoming available to more surgeons and patients worldwide,” said Dr. Francesca de Caro, Specialist in Orthopedics, Knee, and Hip Surgery at Pavia Hospital in Italy. “Expanding access to new technologies, together with ongoing clinical education and scientific exchange, helps advance our ability to address these complex conditions and improve patient care.”

The CARTIHEAL Implant will first be introduced in Austria, Belgium, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Switzerland, and the UK, with other countries expected to follow shortly after. To learn more about Smith+Nephew’s CARTIHEAL AGILI-C Cartilage Repair Implant, please visit our booth at ICRS (#2) and view the product webpage here.

– ends –

Media Enquiries
Dave Snyder                +1 (978) 749-1440
Smith+Nephew        david.snyder@smith-nephew.com

* Over 2-, 4-& 5-year follow-up compared to microfracture or debridement

** Compared to debridement or microfracture

*** Overall KOOS improvements at 48 months; KL 0-1 vs 2-3  

References

1. Altschuler N, Zaslav KR, Di Matteo B, et al. Aragonite-Based Scaffold Versus Microfracture and Debridement for the Treatment of Knee Chondral and Osteochondral Lesions: Results of a Multicenter Randomized Controlled Trial. Am J Sports Med. 2023;51(4):957-967.
2. Kon E, Di Matteo B, Verdonk P, et al. Aragonite-Based Scaffold for the Treatment of Joint Surface Lesions in Mild to Moderate Osteoarthritic Knees: Results of a 2-Year Multicenter Prospective Study. Am J Sports Med. 2021;49(3):588-598.
3. Kon E, Filardo G, Shani J, et al. Osteochondral regeneration with a novel aragonite-hyaluronate biphasic scaffold: up to 12-month follow-up study in a goat model. J Orthop Surg Res. 2015;10:81.
4. Conte P, Anzillotti G, Crawford DC, et al. Differential analysis of the impact of lesions’ location on clinical and radiological outcomes after the implantation of a novel aragonite-based scaffold to treat knee cartilage defects. Int Orthop. 2024;48(12):3117-3126
5. Altschuler N, Zaslav KR, Di Matteo B, et al. Five-Year Follow-up of a Multicenter Randomized Controlled Trial Comparing an Aragonite-Based Scaffold With Microfracture and Debridement for Chondral and Osteochondral Knee Lesions. The American Journal of Sports Medicine. 2026;54(6):1376-1385
6. Kon, E., De Caro, F., Dasa, V., M Scopp, J., Di Matteo, B., Flanigan, D., Shabshin, N., Strickland, S., & Altschuler, N. (2025). Female patients report comparable results to males after the implantation of an aragonite-based scaffold for the treatment of knee chondral and osteochondral defects: a gender-based analysis of a RCT at 4 years’ follow-up. J of Ortho and Traumatology, 26(1), 17.

About Smith+Nephew
Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 17,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.

Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of $6.2 billion in 2025. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.

For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on X, LinkedIn, Instagram or Facebook.

Forward-looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as “aim”, “plan”, “intend”, “anticipate”, “well-placed”, “believe”, “estimate”, “expect”, “target”, “consider” and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew’s most recent annual report on Form 20-F, which is available on the SEC’s website at www. sec.gov, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew’s expectations.

^◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.